Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
02/2012
02/08/2012CN101522665B *庚英衍生物 * Geng Ying derivatives
02/08/2012CN101204509B 一种中药软胶囊及其制备方法 A traditional Chinese medicine soft capsule and its preparation method
02/07/2012US8110587 Aryl ureas as kinase inhibitors
02/07/2012CA2492404C Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
02/07/2012CA2471046C Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine
02/02/2012WO2012015820A1 Composition and method for photodynamic disinfection
02/02/2012WO2012015323A1 Use of a mixture of probiotic bacteria in a mixture with short - chain fatty acids
02/02/2012WO2012015255A2 Novel montelukast 4-halobenzylamine salt and method for preparing montelukast sodium salt by using the same
02/02/2012WO2012014994A1 Naphthalene derivative
02/02/2012WO2012014993A1 Agent for increasing translation initiation factor or translation elongation factor, and use thereof for medical purposes
02/02/2012WO2012014165A1 A method of managing broncho-constrictive condition
02/02/2012WO2012013567A1 Pharmaceutical composition for treatment of respiratory and inflammatory diseases
02/02/2012WO2012013566A1 Pharmaceutical compositions for treatment of respiratory and inflammatory diseases
02/02/2012WO2012012843A1 Modulators of protease activated receptors
02/02/2012WO2011130552A9 Serca2 therapeutic compositions and methods of use
02/02/2012US20120030838 Novel fungal enzymes
02/02/2012US20120029091 Method of controlling the release of an active ingredient from a dosage form
02/02/2012US20120029086 Compositions and Method for Temporary Reduction of Nasal and Sinus Pain
02/02/2012US20120029079 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
02/02/2012US20120029054 RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA)
02/02/2012US20120029053 Short Interfering Ribonucleic Acid (siRNA) for Oral Administration
02/02/2012US20120029052 Short Interfering Ribonucleic Acid (siRNA) for Oral Administration
02/02/2012US20120029048 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies
02/02/2012US20120029044 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof
02/02/2012US20120029034 Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents
02/02/2012US20120029026 Pyridine derivative
02/02/2012US20120029016 Indoles Useful in the Treatment of Inflammation
02/02/2012US20120029014 5-(2--1-hydroxyethyl)-8-hydroxyquinolin-2 (1h)-one for the treatment of lung function
02/02/2012US20120029007 Morphinan compounds
02/02/2012US20120029005 Spiperone derivatives and methods of treating disorders
02/02/2012US20120028995 Novel compounds for medical use as peptidase effectors
02/02/2012US20120028986 2-heteroaryl-pyrrolo [3,4-c]pyrrole derivatives, and use thereof as scd inhibitors
02/02/2012US20120028967 Novel diaza-bicyclononyl-pyrimidinyl derivatives and their medical use
02/02/2012US20120028965 Compounds useful as protein kinase inhibitors
02/02/2012US20120028950 Substituted heterocyclylbenzylpyrazoles and use thereof
02/02/2012US20120028941 Pharmaceutical Product Comprising a P38 Kinase Inhibitor and a Second Active Ingredient
02/02/2012US20120028940 Functionally selective azanitrile alpha-2c adrenoreceptor agonists
02/02/2012US20120028939 Substituted naphthyridines and their use as medicaments
02/02/2012US20120028938 Pyrazole compounds as crth2 antagonists
02/02/2012US20120028932 Drug combinations containing pde4 inhibitors and nsaids
02/02/2012US20120028921 Methods and compositions using oxidized phospholipids
02/02/2012US20120028896 Use of fibroblast growth factor fragments
02/02/2012US20120028880 Vegfr-1/nrp-1 targeting peptides
02/02/2012US20120027879 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
02/02/2012US20120027877 Nitric oxide generator and non-deliquescent tablet for use in same
02/02/2012US20120027863 Pharmaceutical Compositions for Inhalation
02/02/2012US20120027843 Hb-egf bound protein complex
02/02/2012US20120027806 Dose selection of adjuvanted synthetic nanocarriers
02/02/2012US20120027786 Genetically programmable pathogen sense and destroy
02/02/2012US20120027771 Affinity purified human polyclonal antibodies against viral, bacterial and/or fungal infections and methods of making and using the same
02/02/2012US20120027754 Treatment and Prevention of Chronic Asthma Using Antagonists of Integrin AlphavBeta6
02/02/2012US20120027742 Methods for treating adult respiratory distress syndrome
02/02/2012US20120027714 Segmented Polymers and Their Conjugates
02/02/2012US20120027692 Pyrrolopyrimidinedione and its therapeutic use
02/02/2012US20120027691 Cinnamic Acid-Based Oligomers and Uses Thereof
02/02/2012US20120027686 Hk1-binding proteins
02/02/2012US20120024743 Transdermal pharmaceutical preparations
02/02/2012CA2810163A1 A method of managing broncho-constrictive condition
02/02/2012CA2806823A1 Use of a mixture of probiotic bacteria in a mixture with short - chain fatty acids
02/02/2012CA2806740A1 Use of rasagiline for the treatment of olfactory dysfunction
02/02/2012CA2806094A1 Composition and method for photodynamic disinfection
02/01/2012EP2412384A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
02/01/2012EP2412372A1 2-Aminooxazole derivatives for use as TRPV1 antagonists for treating i.a. pain, inflammation, neurodegenerative diseases or gastrointestinal diseases
02/01/2012EP2411518A2 Rna interference mediated inhibition of the high affinity ige receptor alpha chain (fcerla) gene expression using short interfering nucleic acid (sina)
02/01/2012EP2411516A1 RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
02/01/2012EP2411358A1 Leukotriene b4 inhibitors
02/01/2012EP2411019A2 RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
02/01/2012EP2411018A2 RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
02/01/2012EP2411008A1 Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
02/01/2012EP2411004A1 Use of andrographolide compounds for treating inflammation and airway disorders
02/01/2012EP2411003A1 Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd)
02/01/2012EP2410999A2 Curcuminoids and its metabolites for the application in allergic ocular/nasal conditions
02/01/2012EP2285390B1 Method for obtaining an extract of cranberry pulp residues for use in the prevention and treatment of conditions such as caries, gingivitis or sore throats.
02/01/2012EP1472353B1 Group b streptococcus antigen
02/01/2012EP1286989B1 Prodrug of an ICE inhibitor
02/01/2012CN1951899B 阿司匹林触发的脂质介体 Aspirin-triggered lipid mediators
02/01/2012CN102341398A Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
02/01/2012CN102341395A 3h-imidazo [4, 5 -c] pyridine- 6 -carboxamides as anti- inflammatory agents
02/01/2012CN102341386A Pyridine derivative
02/01/2012CN102341385A Piperazine compound capable of inhibiting prostaglandin d synthase
02/01/2012CN102341384A P38 map kinase inhibitors
02/01/2012CN102341371A Bis aromatic compounds for use as lct4 synthase inhibitors
02/01/2012CN102341103A Novel Use of Fibrates
02/01/2012CN102337263A siRNA (Small interfering ribonucleic acid) capable of inhibiting expression of enterovirus 71 type gene, composition and application
02/01/2012CN102336716A 嘧啶衍生物 Pyrimidine derivatives
02/01/2012CN102336714A Hydantoin ibuprofen derivative and synthetic method and application thereof
02/01/2012CN102335408A Cassia twig decoction preparation for treating anaphylactic rhinitis and preparation method thereof
02/01/2012CN102335375A Pharmaceutical composition for treating lung diseases and application thereof
02/01/2012CN102335373A Chinese medicinal composition for treating upper respiratory tract infection, and preparation method thereof
02/01/2012CN102335372A Medicament for resisting virus, relieving cough, eliminating sputum and treating flu cough and preparation method thereof
02/01/2012CN102335357A Phlegm eliminating and convulsion arresting powder and application thereof
02/01/2012CN102335345A Chinese medicinal composition for nourishing yin, clearing heat, and moistening lung for arresting cough, and its preparation method
02/01/2012CN102335329A Medicine for treating emphysema, and preparation method thereof
02/01/2012CN102335327A Pharmaceutical composition for treating asthma
02/01/2012CN102335325A Method for processing fritillary decoction pieces
02/01/2012CN102335321A Fresh flower lozenge with function of preventing cold
02/01/2012CN102335303A Chinese medicinal effective-part composition for treating cold in children and preparation method thereof
02/01/2012CN102335293A Preparation method of medicinal powder for treating various lithiases
02/01/2012CN102335274A Chinese medicinal composition for preventing and treating inflammation-related diseases
02/01/2012CN102335257A Chinese medicinal herb preparation of granules of children cough caused by lung heat and preparation method thereof
1 ... 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... 878